Aims
The aims of MPN&MPNr-EuroNet’s Sixteen meeting to be held in Belgrade, Serbia, on May 05-06 2023 are:
to share information on the newest developments in MPNs and related congenital diseases,
to exchange and diffuse the latest information and recommendations on the molecular assays developed for diagnosis or research in laboratories working on MPNs and related diseases across Europe. NGS and novel technologies will be special focuses of this meeting;
to provide recommendations for therapy of MPN;
to discuss and plan for the various tasks and objectives of the three MPN&MPNr-EuroNet working groups (WG);
to help and mentor young scientists interested in MPNs and related congenital
diseases.
To do so, abstracts will be selected for short talks in the different sessions. Posters will
be presented during the whole length of the meeting.
Plenary sessions will cover the newest knowledge in MPNs, hereditary erythrocytosis and thrombocytosis. Each WG will convene under the direction of the WG chairs. New participants are encouraged to become actively involved in specific WG tasks.
Objectives
Participants to the fifteenth MPN&MPNr-EuroNet meeting will have the opportunity to hear from international experts about the newest developments in the molecular diagnosis of MPNs and related congenital/hereditary diseases. They will have the opportunity to present their own work and original diagnostic assays, and exchange with colleagues and experts on the newest genes and techniques of interest in the field of MPNs, congenital erythrocytosis . By joining one or more of MPN&MPNr-EuroNet working groups, they will be able to contribute actively, productively and durably in innovation, optimization and standardization of the biological diagnosis of MPNs and related congenital diseases in Europe.
Keywords
molecular diagnosis, myeloproliferative neoplasms, congenital erythrocytosis, standardization, European network
More info
Click on the following link to get more info about MPN&MPNr-EuroNet.
Abstract Submission
Participants are encouraged to submit an abstract in relation to the diagnosis of MPNs, hereditary erythrocytosis and thrombocytosis, new mutations and gene editing in MPNs, hereditary erythrocytosis and thrombocytosis, the histopathology, pathogenesis and inflammation in MPNs, the JAK/STAT and other signaling pathways and the mechanism of oxygen sensing. NGS and novel technologies will be the special focuses of this meeting.. Early stage researchers and junior biologists and clinicians are especially encouraged to submit abstracts.
Abstracts should be composed as follows:
Title
Names of co-authors
Affiliations
E-mail address of corresponding author
Text (maximum 2000 characters, including spaces).
All abstracts will be assembled in an abstract book that will be distributed to participants during the meeting.
The deadline for submission of abstracts is MARCH 25TH, 2023
In order to submit an abstract, participants should first be registered, then, being logged in, choose Abstract in the menu bar on Registration page.
16th MPN&MPNR-EURONET CONFERENCE
NOVELTIES IN THE PATHOGENESIS, DIAGNOSIS AND TREATMENT OF MYELOPROLIFERATIVE NEOPLASMS AND HEREDITARY ERYTHROCYTOSIS
Address: The Congress Hall in the building of the Dean’s Office of the Faculty of Medicine, University of Belgrade, at the address Dr. Subotića starijeg 8, 11000 Belgrade.
Day 1: May 5th 2023.
| Time | Title of presentation | Lecturer |
| 11:30 – 12:00 | Registration | |
| 12:00 – 12:05 | Welcome and Schedule | Danijela Leković |
| Special session: Pathogenesis and therapy of MPN | Chair: Andrija Bogdanović | |
| 12:05 – 12:20 | MPN in the light of the new WHO classification 2023 | Andrija Bogdanović |
| 12:20 – 12:50 | Early steps in the disease initiation of myeloproliferative neoplasms | Radek Skoda |
| 12:50 – 13:20 | A Paradigm Shift in The Diagnosis and Treatment of MPNs. Sooner rather than Later. Rationales and Perspectives. | Hans Carl Hasselbalch |
| 13:20 – 13:40 | Role of IL-10R signaling in MPNs | Angela Fleischman |
| 13:40 – 13:50 | Discussion | |
| 13:50 – 14:50 | Lunch time | |
| 14:50 – 15:10 | Round table: Pathogenesis of MPNs |
Radek Skoda Vladan Čokić Andrija Bogdanović Angela Fleischman |
| WG1 session: New Advances in Treatment of MPNs | Chair: Mary Frances McMullin | |
| 15:10 – 15:40 | Advances in treatment of myelofibrosis | Mary Frances McMullin |
| 15:40 – 16:00 | Role of transplantation in era of new drugs in MPNs | Milena Todorović-Balint |
| 16:00 – 16:20 | Targeting Metabolic Dependencies in MPNs | Tata Nageswara Rao |
| 16:20 – 16:30 | Discussion | |
| 16:30 –16:45 | Round table: Current Approach to Treatment of MPNs |
Hans Carl Hasselbalch Mary Frances McMullin Danijela Leković |
| 16:45 – 17:00 | Pause | |
| WG2 session: Thrombosis in MPNs | Chair: Danijela Leković | |
| 17:00 – 17:15 | Risk of thrombotic complications in MPNs patients | Marta Sobas |
| 17:15 – 17:35 | Mutation profile dependence in thrombosis of MPNs | Vladan Čokić |
| 17:35 – 17:50 |
Site-specific thrombosis in MPNs- diagnostic and treatment approach |
Danijela Leković |
| 17:50 – 18:00 | Discussion |
Day 2: May 6th 2023.
| Time | Title of presentation | Lecturer |
| WG3 session: Mutations and management of hereditary Erythrocytosis | Chair: Francois Girodon | |
| 09:00- 09:30 | European collaborative studies of hereditary erythrocytosis associated with mutations in hypoxia-related genes | Betty Gardie |
| 09:30 – 09:50 | Targeted Next Generation Sequencing as strategy for the Diagnosis of Familial Erythrocytosis in Slovenia clinical practice | Nataša Debeljak |
| 09:50 – 10:20 | Erythrocytosis with EPOR mutations: what treatment? | Francois Girodon |
| 10:20 – 10:40 | Diagnosis and management of non‑clonal erythrocytosis remains challenging: a single centre clinical experience | Saša Anžej Doma |
| 10:40 – 10:50 | Discussion | |
| 10:50 – 11:00 | Pause | |
| WG4 session: Poster session | Chair: Nataša Debeljak | |
| 11:00– 11:05 | Does JAK2 mRNA hold diagnostic promise in MPN? | Igor Olkhovskiy |
| 11:05– 11:10 | The CO-rebreathing method is a reliable test in determining the Red Cell Mass: the old pots make the best soups | Nada Maaziz |
| 11:10– 11:15 | Idiopathic erythrocytosis and the presence of multiple altered genes | Andrea Benetti |
| 11:15– 11:20 | Do cytokines alterations play a role in PV and ET thrombotic risk? | Edoardo Peroni |
| 11:20– 11:25 | Identified variant of unknown significance in Slovenian patients with congenital erythrocytosis | Aleša Kristan |
| 11:25– 11:30 | NOS enzymes mediate hydroxyurea-induced cytostasis in erythroid progenitors | Milica Vukotić |
| 11:30– 11:35 | Unfavorable predictors of survival among 816 patients with polycythemia vera: a single university center study | Isidora Arsenović |
| 11:35 – 12:00 | Discussion and take-home messages |
Mary Frances McMullin Francois Girodon Nataša Debeljak Vladan Čokić |
| Title | Name and surname | Affiliation | Department | Country |
|---|---|---|---|---|
| Prof | Vladan Čokić | Institute for Medical Research, University of Belgrade | Department of molecular oncology | Serbia |
| Dr | Biljana Grčar Kuzmanov | Institute of Oncology Ljubljana | pathology | Slovenia |
| Prof | Nataša Debeljak | Faculty of Medicine University of Ljubljana | Institute of Biochemistry and Molecular Genetics | Slovenia |
| Dr | Danijela Leković | University Clinical Center of Serbia | Clinic of Hematology | Serbia |
| Prof | Mary Frances McMullin | Queen's University, Belfast | CME | United Kingdom |
| Prof | Andrija Bogdanović | Clinic of Hematology, University Clinical Center of Serbia | Outpatient and Diagnostic Department | Serbia |
| Ms | Maria Laura Fox | Vall d´hebron Hospital | Spain | |
| Dr | Tata Nageswara Rao | Canton Hostpital St.HGallen | Department of Oncology and Hemattology | Switzerland |
| Dr | Marija Popova-Labachevska | University clinic for hematology | hematology | Macedonia |
| Prof | FRANCOIS GIRODON | UNIVERSITY HOSPITAL DIJON | LABORTORY OF HEMATOLOGY | France |
| Ms | Nada Maaziz | Dijon Hospital | France | |
| Dr | Tijana Subotički | Institute for medical research | Molecular oncology | Serbia |
| Dr | Dragoslava Đikić | Institute for Medical Research | Serbia | |
| Dr | Olivera Mitrović Ajtić | Institute for Medical Research, National Institute of Republic of Serbia, University of Belgrade | Group for Molecular Oncology | Serbia |
| Ms | Emilija Živković | Institute for Medical Research | Molecular oncology | Serbia |
| Dr | Teodora Dragojevic | Institute for Medical Research | Molecular oncology | Serbia |
| Dr | Milica Vukotic | Institute for Medical Research, University of Belgrade | Molecular Oncology | Serbia |
| Dr | Dragana Marković | University of Belgrade, Institute for medical research, National Institute of Republic of Serbia | Group for Immunology | Serbia |
| Dr | Suncica Kapor | KBC "Dr Dragisa Misovic-Dedinje" | Hematology | Serbia |
| Dr | Igor Olkhovskiy | Federal State budgetary Institution Hematology Research Center Department of Health | Krasnoyarsk branch | Russian Federation |
| Ms | Nada Maaziz | Dijon Hospital | France | |
| Dr | Andrea Benetti | University of Padua | Department of Medicine - DIMED | Italy |
| Dr | Edoardo Peroni | Veneto Institute of Oncology | Immunology and Molecular Oncology Unit | Italy |
| Ms | Aleša Kristan | University of Ljubljana, Faculty of Medicine | Institute of Biochemistry and Molecular Genetics | Slovenia |
| Dr | Saša Anžej Doma | UMC Ljubljana | Hematology Department | Slovenia |
| Dr | Dragana Marković | University of Belgrade, Institute for medical research, National Institute of Republic of Serbia | Group for Immunology | Serbia |
| Dr | Momčilović Sanja | Institute for Medical Research | Group of Neuroendocrinology | Serbia |
| Dr | Irina Maslovaric | nstitute for Medical Research, University of Belgrade, Belgrade | Immunology | Serbia |
| Dr | Dijana Sefer | Clinic For Hematology, University Clinical Center of Serbia | Laboratory diagnostic dpt | Serbia |
| Prof | Betty GARDIE | Ecole Pratiques des Hautes Etudes | France | |
| Dr | Zlatko Pravdic | Clinic of Hematology UCCS | Serbia | |
| Dr | Stojicevic Svetlana | MPN | Hematology | Serbia |
| Dr | Aleksandra Novkovic | Clinical Hospital Center Zemun | Serbia | |
| Dr | Evica Simonovic | Hematolog | Internal | Serbia |
| Prof | Irina Panovska-Stavridis | University Clinic of hematology-Skopje | North Macedonia | |
| Prof | Bojana Beleslin Čokić | University Clinical Center of Serbia | Clinic for Endocrinology, Diabetes and Metabolic Diseases | Serbia |
| Dr | Maria Ivanova | Hematology | RF | |
| Dr | Juan Santibanez | IMI, University of Belgrade | Molecular oncology | Serbia |
| Dr | Mark Catherwood | Belfast City Hospital | Hematology | United Kingdom |
| Mr | Miloš Diklić | Institute for medical research | Molecular oncology | Serbia |
| Prof | Nataša Debeljak | Faculty of Medicine, University of Ljubljana | Institute of Biochemistry and Molecular Genetics | Slovenia |
| Dr | Nevenka Ridova | University Clinic for Hematology | North Macedonia |
MPN&MPNR-EURONET 16TH MEETING
BELGRADE, SERBIA, MAY 5-6, 2023.
Faculty of medicine, University of Belgrade
General information
General information
Contribution
Belgrade - Touristic information
Scientific committee
Organising committee
Nataša Debeljak,
Vladan Čokić,
Danijela Leković,
Andrija Bogdanović
How to register?
To register, click REGISTRATION, fill out and submit the form with personal information, verify the
information entered.
Even if you are a MPNrEuronet member or a registered participant of this or previous meetings or
training school, you need to restart the whole registration process and click on REGISTRATION, fill in
the form with the personal data and submit it, verify the registered information.
Deadlines
– MARCH 25TH, 2023: ABSTRACT SUBMISSION (for poster and oral presentations)
– APRIL 10TH, 2023: REGISTRATION, no registration fees.
Data Use Agreement
By registering for this meeting, you (the delegate) agree that your personal data will be processed for registration and handling purposes only, as well as to send you information in connection with the symposium via e-mail. Any personal data will be solely used in accordance with current EU data protection legislation (GDPR) and will not be disclosed to a third party without the delegate written consent. If you will submit an abstract for this symposium it will be published on the symposium internet site and in the book of abstracts. If you do not submit the data indicated as we cannot complete your registration.
How to modify my data, submit and/or load an abstract?
Once registered to this fifteenth meeting, you may come back at any time to your registration form by LOGIN with your last name and password, in order to:
⦁ modify any personal information for registration,
⦁ submit an abstract,
⦁ load your abstract file.
Golden sponzor of MPN&MPNR-EURONET 16TH MEETING
SILVER SPONSORS OF THE MPN&MPNR-EURONET 16TH MEETING
OTHER SPONSORS OF THE MPN&MPNR-EURONET 16TH MEETING
